Literature DB >> 32725366

Factors affecting patient choice for continued observation versus intervention for pelvic organ prolapse.

Marieme Mbaye1, L Autumn Edenfield1, Abbigail Woll1, Steven E Swift2.   

Abstract

INTRODUCTION AND HYPOTHESIS: To analyze the reasons for eventual choice of a therapeutic intervention in subjects who initially chose observation for bothersome pelvic organ prolapse (POP) over therapeutic intervention at their first urogynecology clinic visit.
METHODS: This is a retrospective cohort study of women with bothersome POP who initially chose observation over therapeutic intervention at one institution from 2002 to 2015. Subjects were followed over time with sequential pelvic organ prolapse quantification examinations (POP-Q) and assessments of symptoms and bother utilizing non-validated standard questions. Subjects were divided into two groups: (1) those who chose continued observation versus (2) those who chose therapeutic intervention with either pessary or surgery. Demographic information, POP-Q examinations, and POP symptoms and bother were collected. We analyzed which clinical variables influenced patient decision to elect for therapeutic intervention.
RESULTS: A total of 111 subjects were enrolled. The distribution of initial POP-Q stage was: stage 2 = 54%; stage 3 = 45%; stage 4 = 1%. Median follow-up was 24 months (range 6 and 110 months). At their last recorded visit, 73 subjects (66%) continued observation and 38 subjects (34%) chose pessary or surgical intervention. We investigated clinical factors for choosing intervention. Increase in POP symptom bother was the only variable that remained significant in determining patient choice of a therapeutic intervention (p < 0.001) after confounding factors were controlled for using multivariate regression analysis.
CONCLUSION: In subjects with bothersome POP who initially choose observation and subsequently elect to pursue a therapeutic intervention, worsening symptom bother is the most important factor.

Entities:  

Keywords:  Clinical observation; Factors affecting choice; Pelvic organ prolapse

Year:  2020        PMID: 32725366     DOI: 10.1007/s00192-020-04466-3

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  8 in total

1.  An International Urogynecological Association (IUGA) / International Continence Society (ICS) joint report on the terminology for female pelvic organ prolapse (POP).

Authors:  Bernard T Haylen; Christopher F Maher; Matthew D Barber; Sérgio Camargo; Vani Dandolu; Alex Digesu; Howard B Goldman; Martin Huser; Alfredo L Milani; Paul A Moran; Gabriel N Schaer; Mariëlla I J Withagen
Journal:  Int Urogynecol J       Date:  2016-02       Impact factor: 2.894

2.  Outcomes of observation as therapy for pelvic organ prolapse: a study in the natural history of pelvic organ prolapse.

Authors:  Alienor S Gilchrist; William Campbell; Hannah Steele; Hema Brazell; Jonathon Foote; Steven Swift
Journal:  Neurourol Urodyn       Date:  2012-08-20       Impact factor: 2.696

3.  An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the conservative and nonpharmacological management of female pelvic floor dysfunction.

Authors:  Kari Bo; Helena C Frawley; Bernard T Haylen; Yoram Abramov; Fernando G Almeida; Bary Berghmans; Maria Bortolini; Chantale Dumoulin; Mario Gomes; Doreen McClurg; Jane Meijlink; Elizabeth Shelly; Emanuel Trabuco; Carolina Walker; Amanda Wells
Journal:  Int Urogynecol J       Date:  2016-12-05       Impact factor: 2.894

Review 4.  Pelvic organ prolapse.

Authors:  J Eric Jelovsek; Christopher Maher; Matthew D Barber
Journal:  Lancet       Date:  2007-03-24       Impact factor: 79.321

5.  Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence.

Authors:  A L Olsen; V J Smith; J O Bergstrom; J C Colling; A L Clark
Journal:  Obstet Gynecol       Date:  1997-04       Impact factor: 7.661

6.  Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery.

Authors:  Jennifer M Wu; Catherine A Matthews; Mitchell M Conover; Virginia Pate; Michele Jonsson Funk
Journal:  Obstet Gynecol       Date:  2014-06       Impact factor: 7.661

7.  Forecasting the prevalence of pelvic floor disorders in U.S. Women: 2010 to 2050.

Authors:  Jennifer M Wu; Andrew F Hundley; Rebekah G Fulton; Evan R Myers
Journal:  Obstet Gynecol       Date:  2009-12       Impact factor: 7.661

8.  Progression and remission of pelvic organ prolapse: a longitudinal study of menopausal women.

Authors:  Victoria L Handa; Elizabeth Garrett; Susan Hendrix; Ellen Gold; John Robbins
Journal:  Am J Obstet Gynecol       Date:  2004-01       Impact factor: 8.661

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.